NasdaqGS:ANABBiotechs
Is It Too Late To Consider AnaptysBio (ANAB) After Its 373% One Year Surge?
Wondering whether AnaptysBio at around US$66.76 is still worth your attention, or if most of the value story is already reflected in the price?
The stock has posted returns of 13.4% over the last 7 days, 17.7% over 30 days, 48.5% year to date, and 372.7% over the past year. This will naturally raise questions about how those moves line up with the underlying value.
Recent coverage has focused on AnaptysBio's position in the biotech space and how sentiment around its pipeline and partnerships...